Related Experiment Video
Updated: May 21, 2026

Local Anesthetic Thoracoscopy for Undiagnosed Pleural Effusion
Published on: November 10, 2023
Comparing Treatment Modalities For Parapneumonic Pleural Empyema In Children: What To Choose And When, A
Carolina Soares-Aquino1, Sofia Vasconcelos-Castro1, Norberto Estevinho1
1Department of Paediatric Surgery, Centro Hospitalar Universitário de São João, Portugal.
Insights
For pediatric parapneumonic pleural empyema (PPE), simple drainage is ineffective. Thoracoscopic decortication and fibrinolysis show similar effectiveness, but decortication offers a shorter treatment duration and is recommended when fibrinolysis is contraindicated.
Area of Science:
- Pediatric Pulmonology
- Thoracic Surgery
- Infectious Diseases
Background:
- Parapneumonic pleural empyema (PPE) is a frequent pediatric condition.
- Optimal treatment strategies for pediatric PPE remain undetermined.
- This study evaluates and contrasts different therapeutic approaches for PPE in children.
Purpose of the Study:
- To compare the effectiveness and outcomes of various treatments for pediatric parapneumonic pleural empyema.
- To identify the most suitable treatment based on resolution times, failure rates, and complications.
- To provide evidence-based recommendations for managing pediatric PPE.
Main Methods:
- Retrospective analysis of 77 pediatric PPE cases (2012-2024).
- Evaluation of demographics, treatment timelines, resolution, failure rates, and complications.
- Exclusion of simple effusions and bilateral pneumonias; lung necrosis contraindicating fibrinolysis.
Main Results:
- Intrapleural fibrinolysis was the most common initial treatment (58%), followed by thoracoscopic decortication (29%).
- Treatment failure rates were 100% for simple drainage, 22% for fibrinolysis, and 9% for thoracoscopic decortication.
- Thoracoscopic decortication demonstrated a shorter treatment duration (13 days) compared to fibrinolysis (17 days) without increased complications.
Conclusions:
- Simple drainage is not recommended for pediatric parapneumonic pleural empyema.
- Thoracoscopic decortication and fibrinolysis are equally effective in terms of failure rates.
- Thoracoscopic decortication is recommended for prompt use, especially when fibrinolysis is contraindicated due to necrotizing pneumonia, due to its shorter treatment duration.
Introduction:
Parapneumonic pleural empyema (PPE) is common in children, however, the most appropriate treatment is not established. We aimed to analyse and compare treatments for PPE and its outcomes.
Methods:
Single-centre retrospective analysis of PPE cases from 2012-2024, concerning demographics, times until treatment and resolution, failure, alternative treatments, complications and follow-up. Lung necrosis contraindicated fibrinolysis; simple effusions and bilateral pneumonias were excluded. Time until treatment was considered after the diagnosis of PPE.
Results:
77 cases were identified with a median age of 5 years. The most common initial treatment was intrapleural fibrinolysis (58%), followed by thoracoscopic decortication (29%) and simple drainage (13%). Failure happened after all (10/10) drainages, 22% (10/45) of fibrinolysis and 9% (2/22) of thoracoscopies. Compared to thoracoscopy, fibrinolysis had no difference in failure (p=0.310) but had a longer treatment duration (17 versus 13 days, p=0.004). Excluding failures, no difference was found in treatment duration, postoperative fever and complications.
Conclusion:
While simple drainage of PPE should not be attempted, thoracoscopic decortication and fibrinolysis seem equally effective. There was a shorter treatment duration with thoracoscopic decortication and no increase in complications, so the authors recommend it should be employed promptly when fibrinolysis is contraindicated, as in necrotizing pneumonia.
Related Concept Videos
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumothorax-II
Clinical Manifestations:
Endoscopic Studies II: Thoracocentesis
Description
Excess pleural fluid or air may accumulate in some respiratory disorders in the thoracic cavity. To treat pleural effusion, a physician conducts thoracentesis by carefully piercing the chest wall and entering...
Pneumonia III: Complications and Assessment
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care